Title III – COMING INTO EFFECT OF THE CODE
38. COMING INTO EFFECT AND TRANSITIONAL PROVISIONS OF THE CODE
This Code comes into effect on 27 May 2016 and revokes those that were in effect up to this date.
Notwithstanding the foregoing, the disclosure on 2017 of the Transfers of Value made during 2016, may be done in accordance with the consent rules included in the previous edition of the Code, in effect until 26 May 2016.
Transfers of Value made by pharmaceutical companies from 1 January 2017 to Healthcare Professionals shall not require the previous consent granted by said Healthcare Professionals, and will be published on each reporting period on an individual basis, except those covered in article 18.5.
In any case, for the first data publication on June 2016, of Transfers of Value made during 2015, pharmaceutical companies shall have already in place in their websites, the measures established by the report issued by the SDPA, of 22 April 2016 (Code Annex I), with the aim of avoiding further processing of this data.
This Code supersedes and revokes:
The Code of Practice for the Pharmaceutical Industry (June 2014 edition).